Skip to main content
Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
0.922
+0.024 (2.66%)
At close: Apr 28, 2026, 4:00 PM EDT
0.940
+0.018 (1.91%)
After-hours: Apr 28, 2026, 6:23 PM EDT

Standard BioTools Revenue

In the year 2025, Standard BioTools had annual revenue of $85.33M, down -6.24%. Standard BioTools had revenue of $23.80M in the quarter ending December 31, 2025, a decrease of -3.96%.

Revenue (ttm)
$85.33M
Revenue Growth
-6.24%
P/S Ratio
4.23
Revenue / Employee
$219,360
Employees
389
Market Cap
360.93M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202585.33M-5.68M-6.24%
Dec 31, 202491.01M-15.33M-14.42%
Dec 31, 2023106.34M8.39M8.57%
Dec 31, 202297.95M-32.63M-24.99%
Dec 31, 2021130.58M-7.56M-5.47%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Viemed Healthcare 270.28M
OrthoPediatrics 236.35M
Cerus 206.13M
Pacific Biosciences of California 160.01M
RxSight 134.48M
Delcath Systems 85.23M
TriSalus Life Sciences 45.15M
ClearPoint Neuro 36.97M
Revenue Rankings

LAB News

More News